TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Resident breast stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and tolerability of SUPLEXA
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects with treatment success of Actinic Keratosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Less Illicit Opioid Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Suicidal Ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of access to evidence summaries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in the proportion of SPC charts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the severity of paronychia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and safety profile of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean preoperative haemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Taking baby to term
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Retaining custody of baby
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Loneliness and depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of Patient Health Questionnaire (PHQ-9) averages
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in end tidal carbon dioxide values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in cerebral oxygenisation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in optic nerve sheath diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successfully controlled iatrogenic endobronchial bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of physical activity sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: A model
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Feasibility of detecting labeled TG/FA in femoral adipose tissue biopsy samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 4 Neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: DCS signal acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral assessment by Fugl-Meyer Assessment for Upper Limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral assessment by Action Research Arm Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral perfusion calculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate endometrial biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and case number of Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Liver cirrhosis association with SNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Anatomical Recession Rate (ARR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing by 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in parental quality of life at one week after the intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in parental quality of life at three months after the intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in parental distress at one week after the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in parental distress at three months after the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with oropharynx cancer detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of RO resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of life in Whiplash Disability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functionality-Neck Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: recurrence rate of cholecystitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endogenous LH pulse amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Kisspeptin-induced LH pulse amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: change in six-minute walk distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change from baseline in integrated gastric acidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Practicality
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Geometric mean fold rise (GMFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Days alive and able to wash themselves
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: TIMI flow after Primary Percutaneous Coronary Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Metabolism information
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anhedonia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brain disparities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reward-processing disparities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social media use disparities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Standardized quality-of-life measurement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Social Engagement Latency (SEL)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Social Brain Network Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended dose for phase II (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (AEs) / Serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Charlson Co-Morbidity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of aneurysm rupture
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with positive ultrasound findings of brachial plexus injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Logical Memory II subscale (Delayed Paragraph Recall)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: ADCS-PACC composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Olfactory Psychophysical Tasks scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of appointments needed before cycle scheduling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in concerns about environmental chemical contamination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in awareness of possible exposure to chemicals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in willingness to have homes tested for chemical contamination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Freedom from Documented Atrial Arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EACTE incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of accurate spot HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of accurate spot RR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 10 Day SIA Score Change from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of MHM imbalance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refusal rate of alcohol service
Endpoint domain: Adverse events/effects
Primary endpoint: Contraceptive Prevalence Rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Psychometric Hepatic Encephalopathy Score (PHES) from Baseline to 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to Overt Hepatic Encephalopathy (HE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sensitivity and specificity of involved margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Baseline in the Fasting Blood Glucose (mg/dl) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the Fasting Insulin (mU/L) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the HOMA-IR at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants with MG-ADL Total Score Reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of Recurrence of CDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of participants achieving ≥75% reduction in Psoriasis Area of Severity Index score (PASI-75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Erythrocytosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Perception of readiness and confidence for intimacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sex drive/arousal
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Usual pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worst pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scale (VAS) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients able to undergo resection surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline pain intensity on Numeric Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline joint range of motion on universal goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline shoulder disability on Shoulder pain and disability index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline pain pressure threshold on algometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk extensor endurance test (TEET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bilateral side bridge endurance tests (SBET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prone Bridge Test (PBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Rifampicin/Isoniazid/Pyrazinamide 2 hours post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of any component of 3P-MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first occurrence of CV death
Endpoint domain: Mortality/survival
Primary endpoint: Body esteem
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk stratification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed in functional recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Driving test result
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Comfort during hemodialysis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline sexual harassment at eight months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline sexual harassment at one year
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline gendered harassment at eight months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline gendered harassment at one year
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Islet Cell Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Safety of Device
Endpoint domain: Adverse events/effects
Primary endpoint: Complete sensory sciatic nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete motor sciatic nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Need for additional pain relief during surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: proportion of patients with poor postoperative outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption rate constant (Ka) of spironolactone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total clearance from plasma after oral administration (CL/F) of spironolactone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in body weight (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of BBP-398
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Anti-tumor activity of BBP-398
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in microbiome diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microbiome abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virus presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Overall CHR rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (Area under concentration vs time curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Extremity functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of OSA Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of OSA Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Measurement of liver fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional delayed graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: development of vascular thrombotic manifestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of participants with solicited local adverse events (AE) during 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with solicited systemic AE during 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with serious adverse events (SAEs) from study vaccination through the end of the study
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Health Questionnaire 9-modified for adolescents (PHQ-A)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral Activation for Depression-Short Form (BAD-SF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intratumoral pitavastatin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of symptomatic hyponatraemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Maximum force at the adductor pollicis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum speed of contraction at the adductor pollicis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum speed of relaxation at the adductor pollicis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Abdominal Skeletal Muscle Index (SMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neck disability Index score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: intraoperative time of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: post operative hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: early recurrence of the cancer
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with normal platelet levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Outcome of tuberculosis treatment
Endpoint domain: Mortality/survival
Primary endpoint: mass balance recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Thickness of the Hyponychium Fungal Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Subject Perceived Improvement in overall toenail infection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Attention and Auditory Working Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Visual Spatial Working Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Information Processing Speed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Static Balance in a Standing Position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic healing of teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LL-37 levels in the GCF and saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of UTIs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Sperm Motility Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Disease progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Validity and reliability of the Turkish Heart Health Self-efficacy and Self-Management Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with at least one serious/not serious adverse event related to JPS
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of MD Deficiencies (MDDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of CONVIVO
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Solicited local reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited systemic reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal physical examination after UCB-RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal vital signs after UCB-RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with altered value of continuous monitoring of regional cerebral and somatic oxygen saturation after UCB-RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with abnormalities in the result of acid-base balance and ionogram after UCB-RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes